Astec LifeSciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
October 28, 2022 at 07:08 am EDT
Share
Astec LifeSciences Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 1,997.47 million compared to INR 1,025.74 million a year ago. Revenue was INR 2,037.33 million compared to INR 1,034.74 million a year ago. Net income was INR 183.08 million compared to INR 90.72 million a year ago. Basic earnings per share from continuing operations was INR 9.34 compared to INR 4.63 a year ago. Diluted earnings per share from continuing operations was INR 9.34 compared to INR 4.63 a year ago.
For the six months, sales was INR 3,840.13 million compared to INR 2,312.31 million a year ago. Revenue was INR 3,907.1 million compared to INR 2,329.34 million a year ago. Net income was INR 297.08 million compared to INR 220.57 million a year ago. Basic earnings per share from continuing operations was INR 15.16 compared to INR 11.26 a year ago. Diluted earnings per share from continuing operations was INR 15.15 compared to INR 11.25 a year ago.
Astec LifeSciences Limited is an India-based company that is primarily engaged in manufacturing a range of agrochemical active ingredients and pharmaceutical intermediates. The Company operates through the Agrochemicals segment. It manufactures a range of fungicides, insecticides, herbicides, and intermediates for its global customers. The Companyâs products and intermediates includes triazole fungicides, heterocyclic herbicides, sulfonylurea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, silane derivatives, fluorinated aromatic, aliphatic and heterocyclic intermediates, fluorinated aromatic amines, fluorinated pyridine derivatives, fluorinated aromatic carboxylic acids, fluorinated benzyl alcohols, fluorinated ketones and benzophenones, fluorinated heterocyclic mercaptans, heterocyclic mercaptans, thiopyrimidines, aromatic mercaptans, thorium salts, pyrazaloneâs and heterocyclic sulfonyl chlorides.